In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies
ACS Nano · 2025
DOI: 10.1021/acsnano.4c16824 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Ian I Cardle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, Washington 98195-5061, United States. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Peptides, Immunotherapy, Immunotherapy, Adoptive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Washington, Seattle, Washington 98195-5061, United States.
- Seattle Children's Therapeutics, Seattle, Washington 98101, United States.
- Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.
ORCID-Profile: Ian I Cardle, Suzie H Pun, Drew L Sellers
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- National Science Foundation Graduate Research Fellowship Program
- National Cancer Institute
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Cardle, I. I., Scherer, D. R., Jensen, M. C., Pun, S. H., & Sellers, D. L. (2025). In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies. ACS Nano. https://doi.org/10.1021/acsnano.4c16824
Vancouver
Cardle II, Scherer DR, Jensen MC, Pun SH, Sellers DL. In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies. ACS Nano. 2025. doi:10.1021/acsnano.4c16824
BibTeX
@article{Cardle2025,
author = {Cardle, Ian I and Scherer, Dylan R and Jensen, Michael C and Pun, Suzie H and Sellers, Drew L},
title = {In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.4c16824}
}
EUVIMED